References
- Statistics Canada. Health fact sheets: cancer incidence in Canada, 2013. Ottawa (ON): Statistics Canada. 2016 (cited 2022 Nov 30). Available from: www150.statcan.gc.ca/n1/pub/82-625-x/2016001/article/14363-eng.html
- Oliveira CD, Pataky R, Bremner KE, et al. Estimating the cost of cancer care in British Columbia and Ontario: a Canadian inter-provincial comparison. Healthc Policy. 2017;12(3):95–108.
- Surveillance and Reporting, Cancer Care Alberta, Alberta Health Services. Unpublished data extracted and analyzed from DAD, NACRS, and Alberta Cancer Registry sources. (cited 2022 June 20).
- Leuven E, Sianesi B. PSMATCH2: Stata module to perform full mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Version 0.12. 2016 (cited 2022 June 20). Available from: http://ideas.repec.org/c/boc/bocode/s432001.html
- Thanh NX, Patil T, Knudsen C, et al. Return on investment of the primary health care integrated geriatric services initiative implementation. J Ment Health Policy Econ. 2020;23:101–109.
- Thanh NX, Dmytruk K, O’Connell P, et al. Return on investment of the diabetes foot care clinical pathway implementation in Alberta, Canada. Diabetes Res Clin Pract. 2020;165:108241.
- WHO. International classification of diseases for oncology. 3rd ed. (cited 2022 June 20). 2013, Available from: https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf
- Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
- Rennert-May E, Leal J, Thanh NX, et al. The impact of COVID-19 on hospital admissions and emergency department visits: a population-based study. PLOS One. 2021;16(6):e0252441.
- Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2(3):169–188.
- World Health Organization. International classification of diseases for oncology (ICD-O). 3rd ed, 1st revision. ISBN 978 92 4 069212 1 (PDF). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data; 2013.
- Alberta Health. Analytics and performance reporting branch. Overview of Administrative Health Datasets. 2022 (cited 2022 June 20). Available from: https://open.alberta.ca/dataset/657ed26d-eb2c-4432-b9cb-0ca2158f165d/resource/38f47433-b33d-4d1e-b959-df312e9d9855/download/research-health-datasets.pdf
- CIHI. CMG+. 2022 (cited 2022 June 20). Available from: https://www.cihi.ca/en/cmg
- CIHI. Comprehensive Ambulatory Classification System (CACS). 2019, Available from: https://www.cihi.ca/en/comprehensive-ambulatory-classification-system-cacs#:∼:text=The%20Comprehensive%20Ambulatory%20Classification%20System,Care%20Reporting%20System%20(NACRS)
- Alberta Health. Analytics and performance reporting branch. Interactive health data application: Dementia. 2020 (cited 2020 Nov 26). Available from: http://www.ahw.gov.ab.ca/IHDA_Retrieval/selectCategory.do
- Chau I, Kelleher MT, Cunningham DE, et al. Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer. 2003;88(3):354–361.
- Bosch X, Coloma E, Donate C, et al. Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients. Medicine. 2014;93(16):e95.
- Bosch X, Sanclemente-Ansó C, Escoda O, et al. Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain. BMC Cancer. 2018;18(1):1–5.
- Nixon S, Bezverbnaya K, Maganti M, et al. Evaluation of lymphadenopathy and suspected lymphoma in a lymphoma rapid diagnosis clinic. J Clin Oncol Oncol Pract. 2020;16(1):e29-36–e36.